It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession sparked by the ongoing global trade war. Most bigwigs came out with important updates. Among these, Pacira Biosciences, Inc. PCRX was up on a positive patent settlement agreement, while Edgewise Therapeutics EWTX stock